[1] 王莉, 李贵森, 刘志红. 中华医学会肾脏病学分会《慢性肾脏病矿物质和骨异常诊治指导》[J]. 肾脏病与透析肾移植杂志,2013,22(6):554-559.
[2] Bellinghieri G, Santoro D, Savica V. Emerging drugs for hyperphosphatemia. [J]. Expert Opinion on Emerging Drugs,2007,12(3): 355.
[3] Cupisti A, Benini O, Ferretti V, et al. Novel Differential Measurement of Natural and Added Phosphorus in Cooked Ham With or Without Preservatives[J].Journal of Renal Nutrition, 2012,22(6):533-540.
[4] León J.B.,Sullivan C.M.,Sehgal A.R.The prevalence of phosphorus-containing food additives in top-selling foods in grocery stores.[J]Journal of renal nutrition:the official journal of the Council on Renal Nutrition of the National Kidney Foundation.2013;23(4):265-70.e2.
[5] St-Jules D.E., Goldfarb D.S., Pompeii M.L.,et al. Phosphate Additive Avoidance in Chronic Kidney Disease.[J]Diabetes spectrum: a publication of the American Diabetes Association.2017;30(2):101-6.
[6] Food Labeling: Revision of the Nutrition and Supplement Facts Labels. Final rule.[J]Federal register.2016;81(103):33741-999.
[7] Watanabe MT, Araujo RM, Vogt BP, Barretti P, Caramori JCT. Most consumed processed foods by patients on hemodialysis: alert for phosphate containing additives and the phosphate-to-protein ratio. Clin Nutr ESPEN.2016;14:37-41.
[8] Uribarri J, Calvo MS. Hidden sources of phosphorus in the typical American diet: does it matter in nephrology? Semin Dial.2003;16:186-188.
[9] TsaiP.H., Chung C.H., Chien W.C., et al. Effects of calcium-containing phosphate binders on cardiovascular events and mortality in predialysis CKD stage 5 patients.[J] PloS one. 2020;15(10):e024143
[10] Neradova A., Schumacher S.P., HubeekI.,et al. Phosphate binders affect vitamin K concentration by undesired binding, an in vitro study.[J]BMC nephrology.2017;18(1):149.
[11] JanszT.T., Neradova A., VanBallegooijen A.J.,et al. The role of kidney transplantation and phosphate binder use in vitamin K status.[J]PloSone.2018;13(8):e0203157.
[12] MakinoM.,KawaguchiK.,ShimojoH.,etal.Extensivelanthanumdepositioninthe gastric mucosa: the first histopathological report.[J]Pathologyinternational.2015;65(1):33-7.
[13] OhnoA.,MiyoshiJ.,TanabeH.,etal.Gastropathyassociatedwithlanthanumphosphatedepositionthatwasendoscopicallytrackedfor3years.Acasereport.[J]BMCgastroenterology.2020;20(1):292.
[14] Tonellim,Pannun,Mannsb. Oral phosphate binders in patients with kidney failure[J]..N Engl J Med，2010，362(14):1312－1324．
[15] Block G.A.,Fishbane S., Rodriguez M., et al. A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages3-5.[J]American journal of kidney diseases: the official journal of the National Kidney Foundation.2015;65(5):728-36.
[16] Lee C.T., Wu I.W., Chiang S.S., et al. Effect of oral ferric citrate on serum phosphorus in hemodialysis patients: multicenter, randomized, double-blind, placebo-controlled study.[J]Journal of nephrology. 2015;28(1): 105-13.
[17] Lasa J.S., Altamirano M.J., Bracho L.F., et al. Efficacy and safety of intestinal secretagogues for constipation:A systematic review and meta-analysis.[J] Arquivos de gastroenterologia.2018; 55Suppl1(Suppl1):2-12.
[18] King A.J., Siegel M., He Y., et al. Inhibition of sodium/hydrogen exchanger 3 in the gastrointestinal tract by tenapan or reduces paracellular phosphate permeability.[J]Science translational medicine.2018;10(456).
[19] Sumida K., Yamagata K., Kovesdy C.P. Constipation in CKD.[J]Kidney international reports.2020;5(2):121-34.
[20] Zhang Y., Ma T., Zhang P. Efficacy and safety of nicotinamide on phosphorus metabolism in hemodialysis patients: A systematic review and meta-analysis.[J] Medicine.2018;97(41):e12731.
